|
||||||||||||||||||||
| |
| Phenotypic Information (metabolism pathway, cancer, disease, phenome) |
| |
| |
| Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG |
| |
|
| Gene Summary for CBR1 |
| Basic gene info. | Gene symbol | CBR1 |
| Gene name | carbonyl reductase 1 | |
| Synonyms | CBR|SDR21C1|hCBR1 | |
| Cytomap | UCSC genome browser: 21q22.13 | |
| Genomic location | chr21 :37442284-37445462 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001286789.1, NM_001757.3, | |
| Ensembl id | ENSG00000159228 | |
| Description | 15-hydroxyprostaglandin dehydrogenaseNADPH-dependent carbonyl reductase 1carbonyl reductase (NADPH) 1carbonyl reductase [NADPH] 1prostaglandin 9-ketoreductaseprostaglandin-E(2) 9-reductaseshort chain dehydrogenase/reductase family 21C, member 1 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 114830 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000159228 | ||
| HPRD : 00267 | ||
| Vega : OTTHUMG00000086618 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_CBR1 | |
| BioGPS: 873 | ||
| Gene Expression Atlas: ENSG00000159228 | ||
| The Human Protein Atlas: ENSG00000159228 | ||
| Pathway | NCI Pathway Interaction Database: CBR1 | |
| KEGG: CBR1 | ||
| REACTOME: CBR1 | ||
| ConsensusPathDB | ||
| Pathway Commons: CBR1 | ||
| Metabolism | MetaCyc: CBR1 | |
| HUMANCyc: CBR1 | ||
| Regulation | Ensembl's Regulation: ENSG00000159228 | |
| miRBase: chr21 :37,442,284-37,445,462 | ||
| TargetScan: NM_001286789 | ||
| cisRED: ENSG00000159228 | ||
| Context | iHOP: CBR1 | |
| cancer metabolism search in PubMed: CBR1 | ||
| UCL Cancer Institute: CBR1 | ||
| Assigned class in ccmGDB | C | |
| Top |
| Phenotypic Information for CBR1(metabolism pathway, cancer, disease, phenome) |
| Cancer | CGAP: CBR1 |
| Familial Cancer Database: CBR1 | |
| * This gene is included in those cancer gene databases. |
|
|
|
|
|
|
| ||||||||||||||
Oncogene 1 | Significant driver gene in | |||||||||||||||||||
| cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
| KEGG_ARACHIDONIC_ACID_METABOLISM | |
| OMIM | |
| Orphanet | |
| Disease | KEGG Disease: CBR1 |
| MedGen: CBR1 (Human Medical Genetics with Condition) | |
| ClinVar: CBR1 | |
| Phenotype | MGI: CBR1 (International Mouse Phenotyping Consortium) |
| PhenomicDB: CBR1 | |
| Mutations for CBR1 |
| * Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
| There's no structural variation information in COSMIC data for this gene. |
| * From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows CBR1 related fusion information. |
| ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
| Top |
| There's no copy number variation information in COSMIC data for this gene. |
| Top |
|
![]() |
| Top |
| Stat. for Non-Synonymous SNVs (# total SNVs=18) | (# total SNVs=6) |
![]() | ![]() |
(# total SNVs=1) | (# total SNVs=0) |
![]() |
| Top |
| * When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
| GRCh37 position | Mutation(aa) | Unique sampleID count |
| chr21:37444776-37444776 | p.V144I | 2 |
| chr21:37445093-37445093 | p.E249D | 2 |
| chr21:37444800-37444800 | p.P152S | 2 |
| chr21:37445149-37445149 | p.F268C | 1 |
| chr21:37442646-37442646 | p.R78H | 1 |
| chr21:37444855-37444855 | p.G170V | 1 |
| chr21:37442680-37442680 | p.N89N | 1 |
| chr21:37444896-37444896 | p.H184Y | 1 |
| chr21:37443256-37443256 | p.P100S | 1 |
| chr21:37444914-37444914 | p.P190S | 1 |
| Top |
|
![]() |
| Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| # sample |   | 1 |   | 2 | 2 |   |   |   | 3 |   |   | 1 |   |   |   |   |   | 1 |   | 3 |
| # mutation |   | 1 |   | 2 | 2 |   |   |   | 3 |   |   | 1 |   |   |   |   |   | 1 |   | 4 |
| nonsynonymous SNV |   | 1 |   | 1 | 2 |   |   |   | 2 |   |   |   |   |   |   |   |   | 1 |   | 3 |
| synonymous SNV |   |   |   | 1 |   |   |   |   | 1 |   |   | 1 |   |   |   |   |   |   |   | 1 |
| cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
| Top |
| * We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
| Genomic Position | Mutation(aa) | Unique sampleID count |
| chr21:37443282 | p.S143S | 1 |
| chr21:37445149 | p.V144I | 1 |
| chr21:37443324 | p.F158F | 1 |
| chr21:37444758 | p.R159H | 1 |
| chr21:37444775 | p.G170V | 1 |
| chr21:37444776 | p.P190S | 1 |
| chr21:37444820 | p.E249D | 1 |
| chr21:37444822 | p.L257F | 1 |
| chr21:37444855 | p.F268C | 1 |
| chr21:37444914 | p.R78H,CBR1 | 1 |
| * Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
| cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
| Top |
| Gene Expression for CBR1 |
| * CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
| * Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
| Top |
| * This plots show the correlation between CNV and gene expression. |
![]() |
|
![]() |
|
| Top |
| Gene-Gene Network Information |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() |
| ||||
| BCL2L10,FUOM,CBR1,CDC20,CEBPB,FABP5,FAM58A, GSTP1,KRT17,LOC285629,NMB,PDHA1,PPP1R14B,PSMG1, PWP2,RRP1,SFN,TUBA1C,TUBB6,U2AF1,YDJC | ARL4D,CBR1,CBY1,CLTA,CTNNBL1,DRAP1,FKBP2, HARS,LENG1,MEA1,NT5C,NUDC,NUDT1,OS9, PFDN5,PMVK,POLR2F,PPM1G,RAB13,LAMTOR2,SNRNP35 | ||||
![]() |
| ||||
| ATP5G1,ATP5J,ATPIF1,AURKAIP1,UQCC3,C14orf2,FAM207A, DNPH1,CBR1,COX8A,ECHS1,FAM195A,HMOX2,MRPL12, MRPL20,MRPL39,MRPL4,MRPS34,PRELID1,SOD1,STUB1 | APOBEC1,APOM,FUOM,TMEM252,CBR1,DHDH,FOXD1, GLTPD2,HOXC8,HOXC9,KRT14,MEP1B,MMEL1,MS4A8, NAT8B,OTC,SLC6A4,SLC7A7,SULT2B1,TM6SF2,AGMO |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
| Top |
| Top |
| Pharmacological Information for CBR1 |
| DB Category | DB Name | DB's ID and Url link |
| * Gene Centered Interaction Network. |
![]() |
| * Drug Centered Interaction Network. |
| DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
| DB03556 | carbonyl reductase 1 | experimental | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | ![]() | ![]() |
| DB04463 | carbonyl reductase 1 | experimental | 3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol | ![]() | ![]() |
| DB00694 | carbonyl reductase 1 | approved | Daunorubicin | ![]() | ![]() |
| DB00997 | carbonyl reductase 1 | approved; investigational | Doxorubicin | ![]() | ![]() |
| Top |
| Cross referenced IDs for CBR1 |
| * We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
|
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |